Mary Rude is a Gastroenterology physician affiliated with University of Arkansas for Medical Sciences. OpenAlex indexes 27 publications with 506 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
40.3%Calcineurin inhibitor32.7%Tacrolimus89%Cyclosporine Modified11%Part D<11 patientsPurine Antimetabolite4.9%Azathioprine100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
30.5%Proton pump inhibitor13.7%Pantoprazole Sodium100%Part D≥15 patientsBile Acid9.8%Ursodiol100%Part D<11 patients+ 2 more classes in this area
Cardiovascular
24.1%Calcium channel blocker8.8%Amlodipine Besylate100%Part D≥16 patientsBeta blocker5.9%Propranolol Hcl57%Metoprolol Tartrate43%Part D<11 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Similar KOLs
Other experts from the same institution or the same specialty.
Maurizio Zangari, MD
University of Arkansas for Medical Sciences
Jorge Saucedo, MD
University of Arkansas for Medical Sciences
Donald Bodenner, MD
University of Arkansas for Medical Sciences
Sharmilan Thanendrarajan, MD
University of Arkansas for Medical Sciences
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”